Last edition
News about Drug Discovery & Development
US FDA approval for Incyte's Olumiant
Eli Lilly and Company and Incyte announced the US Food and Drug Administration (FDA) has approved Olumiant (baricitinib) for the treatment of Covid-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) with a recommended dose of 4-mg once daily for 14 days.
Drug Discovery & Development | 12/05/2022 | By Sudeep Soparkar | 892
The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs
These miniature organs are used to develop therapies against incurable diseases.
Drug Discovery & Development | 11/05/2022 | By Content editor | 1158
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy